Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Young Min Lee (Busan, Republic of Korea), Young Min Lee. The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 1247

Member's Comments

No comment yet.

Related content which might interest you: Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Prevention and treatment of exacerbations of non-CF bronchiectasis Source: Eur Respir Monogr 2013; 60: 127-136 Year: 2013 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010 Allergic bronchopulmonary aspergillosis complicating COPD is associated with a higher exacerbation rate and a distinct pattern on chest CT scan compared to COPD Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Chronic inhaled corticosteroids in patients with bronchiectasis who suffer an exacerbation Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Can emphysema predict exacerbations and changes in PFTs in COPD? Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 GORD/PPI and exacerbations in adults with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Immunomodulative therapy in young patients with non-CF bronchiectases exacerbations Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001